Cronos Group (NASDAQ:CRON) has been one of the safer pot stocks to invest in, if for no other reason than it is backed by tobacco giant Altria, which owns a 45% stake in the business.
Hereof, is Chronos a buy?
To buy or not to buy
Currently, Cronos has a market cap of $3.32 billion, or an enterprise value (EV) of $1.67 billion after adjusting for its cash balance. Even then, its stock is trading for an expensive 32.7 times revenue. … Meanwhile, HEXO stock’s valuation stands at just 9.3 times EV/Sales.
One may also ask, is Sundial growers a good buy?
The marijuana company’s core business has been struggling. Sundial’s investments in other areas could soon improve its results. The stock is a risky buy due to bottom-line losses and a high cash-burn rate.
Who owns Gramf stock?
The Parent Company (NEO: GRAM. U) (OTCQX: GRAMF) Investor Dashboard
| Employees: | ~600 as of 6/2021 |
|---|---|
| Established: | 2019 |
| CEO: | Steven Allan |